Evidence map›Paper›PMID 34707784›Full record

ReviewOxidative medicine and cellular longevity2021

The Role of Interaction between Mitochondria and the Extracellular Matrix in the Development of Idiopathic Pulmonary Fibrosis.

Kamil Siekacz, Wojciech J Piotrowski, Mikołaj A Iwański, Paweł Górski, Adam J Białas

Open access · hybridAbstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. SCPEP1Frontiers in immunology · 2025
    Article
  15. Melittin alleviates bleomycin-induced pulmonary fibrosisIranian journal of basic medical sciences · 2025
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kamil SiekaczDepartment of Pathobiology of Respiratory Diseases, 1st Chair of Internal Medicine, Medical University of Lodz, Poland.ORCID https://orcid.org/0000-0002-6419-8074
Wojciech J PiotrowskiDepartment of Pneumology and Allergy, 1st Chair of Internal Medicine, Medical University of Lodz, Poland.ORCID https://orcid.org/0000-0003-4506-6006
Mikołaj A IwańskiDepartment of Pathobiology of Respiratory Diseases, 1st Chair of Internal Medicine, Medical University of Lodz, Poland.ORCID https://orcid.org/0000-0001-8710-8986
Paweł GórskiDepartment of Pneumology and Allergy, 1st Chair of Internal Medicine, Medical University of Lodz, Poland.ORCID https://orcid.org/0000-0001-7520-4268
Adam J BiałasDepartment of Pathobiology of Respiratory Diseases, 1st Chair of Internal Medicine, Medical University of Lodz, Poland.ORCID https://orcid.org/0000-0002-3501-167X
Medical University of Lodz · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Idiopathic pulmonary fibrosis (IPF) is a condition which affects mainly older adults, that suggests mitochondrial dysfunction and oxidative stress, which follow cells senescence, and might contribute to the disease onset. We have assumed pathogenesis associated with crosstalk between the extracellular matrix (ECM) and mitochondria, mainly based on mitochondrial equilibrium impairment consisting of (1) tyrosine kinases and serine-threonine kinase (TKs and ST-Ks) activation via cytokines, (2) mitochondrial electron transport chain dysfunction and in consequence electrons leak with lower ATP synthesis, (3) the activation of latent TGF-

Indexed as

AnimalsAntifibrotic AgentsCellular SenescenceDisease ProgressionExtracellular MatrixHumansIdiopathic Pulmonary FibrosisLungMitochondriaMyofibroblastsSignal TransductionAntifibrotic Agents

Identifiers

PMID34707784
PMCPMC8545566
OpenAlexW3206223524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.